Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

101 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Superallowed Gamow-Teller decay of the doubly magic nucleus 100Sn.
Hinke CB, Böhmer M, Boutachkov P, Faestermann T, Geissel H, Gerl J, Gernhäuser R, Górska M, Gottardo A, Grawe H, Grębosz JL, Krücken R, Kurz N, Liu Z, Maier L, Nowacki F, Pietri S, Podolyák Z, Sieja K, Steiger K, Straub K, Weick H, Wollersheim HJ, Woods PJ, Al-Dahan N, Alkhomashi N, Ataç A, Blazhev A, Braun NF, Čeliković IT, Davinson T, Dillmann I, Domingo-Pardo C, Doornenbal PC, de France G, Farrelly GF, Farinon F, Goel N, Habermann TC, Hoischen R, Janik R, Karny M, Kaşkaş A, Kojouharov IM, Kröll T, Litvinov Y, Myalski S, Nebel F, Nishimura S, Nociforo C, Nyberg J, Parikh AR, Procházka A, Regan PH, Rigollet C, Schaffner H, Scheidenberger C, Schwertel S, Söderström PA, Steer SJ, Stolz A, Strmeň P. Hinke CB, et al. Among authors: parikh ar. Nature. 2012 Jun 20;486(7403):341-5. doi: 10.1038/nature11116. Nature. 2012. PMID: 22722192 Free article.
Collagen type I PET/MRI enables evaluation of treatment response in pancreatic cancer in pre-clinical and first-in-human translational studies.
Esfahani SA, Ma H, Krishna S, Shuvaev S, Sabbagh M, Deffler C, Rotile N, Weigand-Whittier J, Zhou IY, Catana C, Catalano OA, Ting DT, Heidari P, Abston E, Lanuti M, Boland GM, Pathak P, Roberts H, Tanabe KK, Qadan M, Castillo CF, Shih A, Parikh AR, Weekes CD, Hong TS, Caravan P. Esfahani SA, et al. Among authors: parikh ar. Theranostics. 2024 Sep 9;14(15):5745-5761. doi: 10.7150/thno.100116. eCollection 2024. Theranostics. 2024. PMID: 39346545 Free PMC article.
Guiding Principles for Community Building in Global Oncology.
Abuali I, Mathew A, Rugengamanzi E, Sainamthip P, Verduzco-Aguirre H, Parikh AR. Abuali I, et al. Among authors: parikh ar. Am Soc Clin Oncol Educ Book. 2024 Jun;44(3):e100045. doi: 10.1200/EDBK_100045. Am Soc Clin Oncol Educ Book. 2024. PMID: 38768401 Free article. Review.
Hypofractionated Radiotherapy-Related Lymphopenia Is Associated With Worse Survival in Unresectable Intrahepatic Cholangiocarcinoma.
Lee G, Kim DW, Smart AC, Horick NK, Eyler CE, Roberts HJ, Pathak P, Goyal L, Franses J, Heather JM, Hwang WL, Grassberger C, Klempner SJ, Drapek LC, Allen JN, Blaszkowsky LS, Parikh AR, Ryan DP, Clark JW, Hong TS, Wo JY. Lee G, et al. Among authors: parikh ar. Am J Clin Oncol. 2024 Aug 1;47(8):373-382. doi: 10.1097/COC.0000000000001108. Epub 2024 May 20. Am J Clin Oncol. 2024. PMID: 38767086
Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment.
Parikh AR, Chee BH, Tsai J, Rich TA, Price KS, Patel SA, Zhang L, Ibrahim F, Esquivel M, Van Seventer EE, Jarnagin JX, Raymond VM, Corvera CU, Hirose K, Nakakura EK, Corcoran RB, Van Loon K, Atreya CE. Parikh AR, et al. Clin Cancer Res. 2024 Jul 15;30(14):2964-2973. doi: 10.1158/1078-0432.CCR-23-3660. Clin Cancer Res. 2024. PMID: 38695832 Free PMC article.
Discordance in Recommendation Between Next-Generation Sequencing Test Reports and Molecular Tumor Boards in India.
Mathew A, Davis S, Boby JM, R I A, Suryavanshi M, Dawood SS, Panda PK, Nag SM, Das A, Rohatgi N, Popat S, Shah RNH, Thampy C, Parikh AR, Yadav S, Mehta P, Singh R, Mukherji D, Shilpakar R, Mullapally SK, Sirohi B. Mathew A, et al. Among authors: parikh ar. JCO Glob Oncol. 2024 Mar;10:e2300330. doi: 10.1200/GO.23.00330. JCO Glob Oncol. 2024. PMID: 38484196 Free PMC article.
Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors.
Corcoran RB, Do KT, Kim JE, Cleary JM, Parikh AR, Yeku OO, Xiong N, Weekes CD, Veneris J, Ahronian LG, Mauri G, Tian J, Norden BL, Michel AG, Van Seventer EE, Siravegna G, Camphausen K, Chi G, Fetter IJ, Brugge JS, Chen H, Takebe N, Penson RT, Juric D, Flaherty KT, Sullivan RJ, Clark JW, Heist RS, Matulonis UA, Liu JF, Shapiro GI. Corcoran RB, et al. Among authors: parikh ar. Clin Cancer Res. 2024 May 1;30(9):1739-1749. doi: 10.1158/1078-0432.CCR-23-3135. Clin Cancer Res. 2024. PMID: 38456660 Free PMC article. Clinical Trial.
RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer.
Singh H, Sahgal P, Kapner K, Corsello SM, Gupta H, Gujrathi R, Li YY, Cherniack AD, El Alam R, Kerfoot J, Andrews E, Lee A, Nambiar C, Hannigan AM, Remland J, Brais L, Leahy ME, Rubinson DA, Schlechter BL, Meyerson M, Kuang Y, Paweletz CP, Lee JK, Quintanilha JCF, Aguirre AJ, Perez KJ, Huffman BM, Rossi H, Abrams TA, Kabraji S, Trusolino L, Bertotti A, Sicinska ET, Parikh AR, Wolpin BM, Schrock AB, Giannakis M, Ng K, Meyerhardt JA, Hornick JL, Sethi NS, Cleary JM. Singh H, et al. Among authors: parikh ar. Clin Cancer Res. 2024 Apr 15;30(8):1669-1684. doi: 10.1158/1078-0432.CCR-23-2581. Clin Cancer Res. 2024. PMID: 38345769 Free PMC article.
101 results